Clascoterone Cream | Therapeutic Cheat Sheet
162101621016210
Clascoterone cream is a novel topical therapeutic agent used to treat acne vulgaris through androgen inhibition. Other androgen inhibitors such as combined oral contraceptive pills and off-label spironolactone can lead to some unwanted side effects such as feminization, gynecomastia, and erectile dysfunction, making them unsuitable for male patients. Unlike other androgen inhibitors used to manage …
Clascoterone cream is a novel topical therapeutic agent used to treat acne vulgaris through androgen inhibition. Other androgen inhibitors such as combined oral contraceptive pills and off-label spironolactone can lead to some unwanted side effects such as feminization, gynecomastia, and erectile dysfunction, making them unsuitable for male patients. Unlike other androgen inhibitors used to manage … Continue reading "Clascoterone Cream | Therapeutic Cheat Sheet"
Acne has profound effects on patients physically and psychologically.
Acne is the most common inflammatory dermatosis seen by Dermatologists with profound effects on patients both physically and psychologically.1 Although extensive research and evidence-based guidelines exist for treatment, most are based on short term randomized controlled trials, leaving a gap in understanding the longer-ter … 
“Jello Skin” is a term that dermatology patients – especially TikTok-using patients – may use in their next office visit. A facialist coined the term when describing glowing, bouncy skin with a lot of collagen similar to Jell-O gelatin.
Are you up-to-date on the latest developments and trends in dermatology? Peruse this list of articles in the consumer press and learn about everything fro … 
Our new series, “The Many Faces of”, showcases side-by-side images of some of the most commonly seen dermatology conditions in an array of skin tones and briefly highlight nuances in clinical presentation. All images featured in the series are part of The Full Spectrum of Dermatology: A Diverse and Inclusive Atlas, a resource developed by co-editors Misty Eleryan, MD, MS, and Adam Friedman, … 
The June 2022 issue of the Journal of Drugs in Dermatology (JDD) focuses on acne and rosacea, with original articles discussing topics such as improving rosacea outcomes in skin of color patients, pediatric and female acne, topical management of facial and truncal acne, and many more. Included in this issue are also case reports on bullous dermatitis and low dose Naltrexone in combination with PRP … 